Ki Young Yoo Selected Research

Ribavirin (Virazole)

3/2022	Low Incidence of Hepatocellular Carcinoma after Antiviral Therapy in Patients with Chronic Hepatitis C and Hemophilia.
6/2015	Highly effective peginterferon α-2a plus ribavirin combination therapy for chronic hepatitis C in hemophilia in Korea.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ki Young Yoo Research Topics

Disease

8	Hemophilia A (Haemophilia) 02/2024 - 06/2015
3	Chronic Hepatitis C 03/2022 - 06/2015
1	Hepatocellular Carcinoma (Hepatoma) 03/2022
1	von Willebrand Diseases (von Willebrand's Disease) 11/2019
1	Hemorrhage 11/2019
1	Hemarthrosis 06/2018
1	Joint Diseases (Joint Disease) 06/2018

Drug/Important Bio-Agent (IBA)

3	Factor VIII (Coagulation Factor VIII)IBA 01/2018 - 12/2015
2	Ribavirin (Virazole)FDA LinkGeneric 03/2022 - 06/2015
2	Antiviral Agents (Antivirals)IBA 03/2022 - 09/2017
1	emicizumabIBA 02/2024
1	InterferonsIBA 03/2022
1	von Willebrand FactorIBA 11/2019
1	Rifampin (Rifampicin)FDA LinkGeneric 06/2018
1	AntibodiesIBA 12/2015

Therapy/Procedure

4	Therapeutics 02/2024 - 06/2015
1	Aftercare (After-Treatment) 03/2022
1	Ligation 11/2019
1	Synovectomy 06/2018